Evidence map›Paper›PMID 38198374›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2024

Post-discharge all-cause mortality in COVID-19 recovered patients hospitalized in 2020: the impact of chronic kidney disease.

Guilherme Schittine Bezerra Lomba, Pedro Henrique Abreu da Silva, Natalia Fonseca do Rosário, Thalia Medeiros, Lilian Santos Alves, Andrea Alice Silva, Jorge Reis Almeida, Jocemir Ronaldo Lugon

Abstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guilherme Schittine Bezerra LombaUniversidade Federal Fluminense, Faculdade de Medicina, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-4493-7287
Pedro Henrique Abreu da SilvaUniversidade Federal Fluminense, Faculdade de Medicina, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-2634-9465
Natalia Fonseca do RosárioUniversidade Federal Fluminense, Faculdade de Medicina, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-5109-085X
Thalia MedeirosUniversidade Federal Fluminense, Faculdade de Medicina, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-5642-4027
Lilian Santos AlvesUniversidade Federal Fluminense, Faculdade de Medicina, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-8576-2239
Andrea Alice SilvaUniversidade Federal Fluminense, Faculdade de Medicina, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-3252-3511
Jorge Reis AlmeidaUniversidade Federal Fluminense, Faculdade de Medicina, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-6155-7978
Jocemir Ronaldo LugonUniversidade Federal Fluminense, Faculdade de Medicina, Departamento de Medicina Clínica, Divisão de Nefrologia, Niterói, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-6791-3910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Brazil, the COVID-19 burden was substantial, and risk factors associated with higher in-hospital mortality rates have been extensively studied. However, information on short-term all-cause mortality and the factors associated with death in patients who survived the hospitalization period of acute SARS-CoV-2 infection is limited. We analyzed the six-month post-hospitalization mortality rate and possible risk factors of COVID-19 patients in a single center in Brazil. This is a retrospective cohort study focused on a six-month follow-up. The exclusion criteria were death during hospitalization, transference to another hospital, and age under 18. We collected data from the charts of all hospitalized patients from March 2020 to December 2020 with a positive RT-PCR test for SARS-CoV-2, resulting in a sample size of 106 patients. The main outcome was death after hospitalization, whereas comorbidities and demographics were evaluated as risk factors. The crude post-hospitalization death rate was 16%. The first 30 days of follow-up had the highest mortality rate. In a Cox regression model for post-hospitalization mortality, previous chronic kidney disease (HR, 4.06, 95%CI 1.46 - 11.30) and longer hospital stay (HR 1.01, 95%CI 1.00 - 1.02) were the only factors statistically associated with death. In conclusion, a high six-month all-cause mortality was observed. Within the six-month follow-up, a higher risk of death was observed for patients who had prior CKD and longer hospital stay. These findings highlight the importance of more intensive medical surveillance during this period.

Indexed as

COVID-19Renal Insufficiency, ChronicAftercareHumansPatient DischargeRetrospective StudiesSARS-CoV-2

Identifiers

PMID38198374
PMCPMC10768652

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.